-
UAE approves Sinopharm’s protein-based vaccine
ExpressPharma
December 29, 2021
The United Arab Emirates (UAE) has approved emergency use of Sinopharm’s protein-based COVID-19 vaccine and it will be available to the public as a booster dose starting January 2022, the health ministry said.
-
Pasaca Capital, Inc. with its portfolio company Innova Medical Group Establish Joint Venture with Sinopharm Group to Improve Access to COVID-19 Vaccines
FirstWordPharma
November 12, 2021
Pasaca Capital Inc, the private equity firm that owns one of the worlds largest COVID-19 test providers, Innova Medical Group, Inc., and Sinopharm's China National Biotech Group (CNBG)...
-
Sinopharm executive suggests vaccinated people accept booster shots after China builds herd immunity
firstwordpharma
August 24, 2021
Zhang Yuntao, chief scientist of Sinopharm's subsidiary China National Biotec Group (CNBG), suggested that vaccinated people in China could choose to accept booster shots when available after herd immunity is built in the country, Global Times reported.
-
UAE rolls out Sinopharm COVID-19 vaccine for children
expresspharma
August 04, 2021
The Gulf Arab state, which has among the world's highest immunisation rates, was already providing the Pfizer-BioNTech vaccine for children aged 12-15.
-
Sinopharm and Sinovac to deliver 550 million vaccine doses to Gavi
pharmaceutical-technology
July 14, 2021
Gavi, the Vaccine Alliance has signed advance purchase agreements (APAs) for a total of up to 550 million doses of Covid-19 vaccines from Sinopharm and Sinovac for supply through the COVAX facility.
-
China's Sinopharm COVID-19 vaccines arrive in Thailand
firstwordpharma
June 21, 2021
A batch of Sinopharm COVID-19 vaccines landed in Bangkok on Sunday, as reported China Daily.
-
WHO grants Sinopharm’s COVID-19 vaccine emergency approval
pharmatimes
May 11, 2021
The World Health Organization (WHO) has approved Sinopharm’s COVID-19 vaccine for emergency use, making it the first jab developed by a non-Western company to gain this recommendation.
-
Sinovac, Sinopharm Show Safety, Efficacy: WHO
NMPA
April 14, 2021
WHO experts say the Chinese vaccine has good efficacy and safety against symptomatic COVID-19.
-
Hungary issues GMP certificate to Sinopharm’s Covid-19 vaccine
pharmaceutical-technology
April 06, 2021
The Hungarian National Institute of Pharmacy and Nutrition has issued a Good Manufacturing Practice (GMP) certificate to China National Pharmaceutical Group’s (Sinopharm) Covid-19 vaccine.
-
Sinopharm seeks EUA for Covid-19 vaccines in Philippines
pharmaceutical-technology
March 02, 2021
Chinese company Sinopharm has submitted an application to the Food and Drug Administration (FDA) of the Philippines for emergency use authorization (EUA) of its Covid-19 vaccines.